S&P 500
(0.47%) 5 045.82 points
Dow Jones
(0.68%) 38 011 points
Nasdaq
(0.38%) 15 744 points
Oil
(-0.23%) $82.50
Gas
(3.39%) $1.770
Gold
(-0.03%) $2 387.80
Silver
(-0.44%) $28.28
Platinum
(-0.04%) $953.80
USD/EUR
(0.15%) $0.938
USD/NOK
(0.28%) $11.02
USD/GBP
(0.06%) $0.803
USD/RUB
(-0.20%) $93.88

Realtime updates for PharmaSGP Holding SE [PSG.DE]

Exchange: XETRA Sector: Pharmaceuticals Industry: Drug Manufacturers—Specialty & Generic
Last Updated18 Apr 2024 @ 09:48

0.00% 21.60

Live Chart Being Loaded With Signals

Commentary (18 Apr 2024 @ 09:48):

PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo...

Stats
Today's Volume 215.00
Average Volume 480.00
Market Cap 258.99M
EPS €0 ( 2024-04-07 )
Next earnings date ( €0 ) 2024-04-29
Last Dividend €0.490 ( 2023-06-29 )
Next Dividend €0 ( N/A )
P/E 17.28
ATR14 €0 (0.00%)

PharmaSGP Holding SE Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PharmaSGP Holding SE Financials

Annual 2022
Revenue: €85.82M
Gross Profit: €76.79M (89.48 %)
EPS: €1.000
Q3 2023
Revenue: €25.97M
Gross Profit: €23.62M (90.95 %)
EPS: €0.400
Q2 2023
Revenue: €25.70M
Gross Profit: €23.32M (90.76 %)
EPS: €0.340
Q1 2023
Revenue: €24.01M
Gross Profit: €21.74M (90.53 %)
EPS: €0.240

Financial Reports:

No articles found.

PharmaSGP Holding SE Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0.490
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)

PharmaSGP Holding SE Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.82 - Stable (16.37%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend €0.450 2022-06-16
Last Dividend €0.490 2023-06-29
Next Dividend €0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 2 --
Total Paid Out €0.940 --
Avg. Dividend % Per Year 0.00% --
Score 3.22 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 5.82
Div. Directional Score 9.01 --
Next Divdend (Est)
(2025-03-31)
€0.393 Estimate 3.00 %
Dividend Stability
0.24 Very Poor
Dividend Score
3.22
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SLL.DE Ex Dividend Knight 2023-05-23 Sporadic 0 0.00%
DB1.DE Ex Dividend Junior 2023-05-17 Annually 0 0.00%
LHOG.F Ex Dividend Junior 2023-08-24 Semi-Annually 0 0.00%
68V.DE Ex Dividend Knight 2023-08-07 Quarterly 0 0.00%
UDC.DE Ex Dividend Junior 2023-07-10 Annually 0 0.00%
ERCB.DE Ex Dividend Junior 2023-09-28 Annually 0 0.00%
NMM.DE Ex Dividend Knight 2023-09-06 Quarterly 0 0.00%
AOMD.DE No Dividend Player 2023-07-17 Sporadic 0 0.00%
XONA.DE Ex Dividend Knight 2023-08-15 Quarterly 0 0.00%
GUI.DE Ex Dividend Knight 2023-08-24 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1541.5006.9310.00[0 - 0.5]
returnOnAssetsTTM0.1141.2006.207.44[0 - 0.3]
returnOnEquityTTM0.4511.5006.109.15[0.1 - 1]
payoutRatioTTM0.392-1.0006.08-6.08[0 - 1]
currentRatioTTM2.560.8002.211.766[1 - 3]
quickRatioTTM2.050.8002.662.13[0.8 - 2.5]
cashRatioTTM1.5461.5002.523.78[0.2 - 2]
debtRatioTTM0.00766-1.5009.87-10.00[0 - 0.6]
interestCoverageTTM5.891.0008.938.93[3 - 30]
operatingCashFlowPerShareTTM2.182.009.2710.00[0 - 30]
freeCashFlowPerShareTTM2.122.008.9410.00[0 - 20]
debtEquityRatioTTM0.0275-1.5009.89-10.00[0 - 2.5]
grossProfitMarginTTM0.9061.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.2461.0007.087.08[0.1 - 0.6]
cashFlowToDebtRatioTTM25.941.00010.0010.00[0.2 - 2]
assetTurnoverTTM0.7420.8008.396.71[0.5 - 2]
Total Score12.21

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM18.241.0008.260[1 - 100]
returnOnEquityTTM0.4512.507.499.15[0.1 - 1.5]
freeCashFlowPerShareTTM2.122.009.2910.00[0 - 30]
dividendYielPercentageTTM2.151.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM2.182.009.2710.00[0 - 30]
payoutRatioTTM0.3921.5006.08-6.08[0 - 1]
pegRatioTTM01.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2681.0005.810[0.1 - 0.5]
Total Score5.82

PharmaSGP Holding SE

PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators